These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 19377514

  • 21. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
    Goto T, Ikuta K, Inamoto Y, Kamoshita S, Yokohata E, Koyama D, Onodera K, Seto A, Watanabe K, Imahashi N, Tsukamoto S, Ozawa Y, Sasaki K, Ito M, Kohgo Y, Miyamura K.
    Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
    [Abstract] [Full Text] [Related]

  • 22. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
    Malcovati L.
    Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
    [Abstract] [Full Text] [Related]

  • 23. Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.
    Tefferi A, Mesa RA, Pardanani A, Hussein K, Schwager S, Hanson CA, Steensma DP.
    Am J Hematol; 2009 May; 84(5):265-7. PubMed ID: 19396855
    [Abstract] [Full Text] [Related]

  • 24. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Soluble transferrin receptors and ferritin in Type 2 diabetic patients.
    Hernández C, Lecube A, Carrera A, Simó R.
    Diabet Med; 2005 Jan; 22(1):97-101. PubMed ID: 15606699
    [Abstract] [Full Text] [Related]

  • 28. Total body iron overload in welder's siderosis.
    Doherty MJ, Healy M, Richardson SG, Fisher NC.
    Occup Environ Med; 2004 Jan; 61(1):82-5. PubMed ID: 14691279
    [Abstract] [Full Text] [Related]

  • 29. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload.
    Ozyilmaz E, Aydogdu M, Sucak G, Aki SZ, Ozkurt ZN, Yegin ZA, Kokturk N.
    Bone Marrow Transplant; 2010 Oct; 45(10):1528-33. PubMed ID: 20118991
    [Abstract] [Full Text] [Related]

  • 32. Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity.
    de la Serna J, Bornstein R, García-Bueno MJ, Lahuerta-Palacios JJ.
    Bone Marrow Transplant; 1999 Jan; 23(1):95-7. PubMed ID: 10037058
    [Abstract] [Full Text] [Related]

  • 33. A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels.
    Au WY, Lam WM, Chu WC, Tam S, Wong WK, Pennell DJ, Lie AK, Liang R.
    Transplant Proc; 2007 Dec; 39(10):3369-74. PubMed ID: 18089387
    [Abstract] [Full Text] [Related]

  • 34. Iron overload in patients with chronic viral hepatitis: how common is it?
    Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, Merli M, Quinti I, Violante N, Caroli S, Senofonte O, Capocaccia L.
    Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.
    Friedman TM, Varadi G, Hopely DD, Filicko J, Wagner J, Ferber A, Martinez J, Brunner J, Grosso D, McGuire L, Korngold R, Flomenberg N.
    Biol Blood Marrow Transplant; 2001 Aug; 7(12):656-64. PubMed ID: 11787528
    [Abstract] [Full Text] [Related]

  • 38. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
    Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Karakan T, Akyol G.
    Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
    [Abstract] [Full Text] [Related]

  • 39. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Dey BR, McAfee S, Sackstein R, Colby C, Saidman S, Weymouth D, Poliquin C, Vanderklish J, Sachs DH, Sykes M, Spitzer TR.
    Biol Blood Marrow Transplant; 2001 Oct; 7(11):604-12. PubMed ID: 11760148
    [Abstract] [Full Text] [Related]

  • 40. Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome.
    Murphy PT, Mitra S, Gleeson M, Desmond R, Swinkels DW.
    Br J Haematol; 2009 Feb; 144(3):451-2. PubMed ID: 19076175
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.